A WREXHAM-based business has announced a £75 million investment in the site.

Ipsen's announcement for its world-renowned neuroscience centre of excellence, coincides with the site's 50th anniversary, which was celebrated with a tree-planting ceremony.

The occasion was attended by the newly appointed Wrexham Mayor Cllr Andy Williams, members of the community, and Ipsen employees, including the company's chief executive officer, David Loew.

Read more: One of the best places to work in the UK - and it's in Wrexham

The event commemorated half a century of researching, developing and manufacturing innovative treatments for patients in more than 90 countries across the world, with the tree-planting serving as a symbol of the company's strong roots in North Wales, sustainable work practices, commitment to the environment, and future growth.

Cllr Williams, who took part in the ceremony, said: "Today marks a significant milestone for Ipsen as a company, and for the Wrexham community. Through the creation of numerous jobs over five decades, Ipsen's Wrexham site has contributed significantly to the growth of the local economy while working sustainably and ethically, making it a shining example to businesses locally and globally.

Read more: 'Everyone loved dad' - family tribute to Wrexham businessman

"From driving global health to 'going green' and helping local students pursue careers in the life sciences sector, Ipsen Wrexham has much to be proud of as a community partner and global innovator."

Ipsen Wrexham, which is the largest of Ipsen's UK sites, uses 100% renewable energy across its production and research units. Earlier in the year, the Wrexham-based global manufacturing site was awarded a grant by the government in recognition of its outstanding contributions to the life sciences ecosystem.

Read more: Pale ale a winner for Wrexham brewery at beer awards

CEO Mr Loew added: "The 50th anniversary of Ipsen's Wrexham site marks a proud moment for our company. We have seen huge growth in demand at this important site, and we are pleased to continue our investment in the area and contribute positively to the local economy."

Ipsen's Wrexham facility undertakes research and development and manufacturing to produce medicines to treat neurological conditions. This latest investment will fund a new state-of-the-art facility, built using the latest in environmentally sustainable technologies, that will enhance the production of Ipsen medicines in the UK.

Ipsen has also been awarded a grant of up to £2.7m from the Government through the Life Sciences Innovative Manufacturing Fund, set up to support businesses investing in life sciences manufacturing projects in the UK.